z-logo
open-access-imgOpen Access
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)
Author(s) -
Michael Feher,
William Hinton,
Anna Forbes,
Neil Munro,
Mark Joy,
David C. Wheeler,
Simon de Lusignan
Publication year - 2022
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/34206
Subject(s) - type 2 diabetes , glucagon like peptide 1 receptor , agonist , medicine , glucagon like peptide 1 , diabetes mellitus , pharmacology , endocrinology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here